Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 8, 2014, Pages 1140-1149

  Bibli, Sophia Iris ^a   Iliodromitis, Efstathios K ^b   Lambertucci, Catia ^c   Zoga, Anastasia ^b   Lougiakis, Nikolaos ^a   Dagres, Nikolaos ^b   Volpini, Rosaria ^c   Dal Ben, Diego ^c   Kremastinos, Dimitrios Th ^b   Tsantili Kakoulidou, Anna ^a   Cristalli, Gloria ^c   Andreadou, Ioanna ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF CAMERINO   (Italy)

Author keywords

adenosine receptor agonists; infarct size; postconditioning; RISK and JAK STAT pathways

Indexed keywords

2 (PHENETHYLTHIO) 5' N ETHYLCARBOXAMIDOADENOSINE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; AR 170; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N6 METHYL 2 PHENETHYNYL 5' N METHYLCARBOXAMIDOADENOSINE,; PROTEIN KINASE B; STAT3 PROTEIN; UNCLASSIFIED DRUG; VT 7; CARDIOTONIC AGENT; PURINERGIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; HEART; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RABBIT;

ANIMALS; CARDIOTONIC AGENTS; HEART; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PURINERGIC P1 RECEPTOR AGONISTS; RABBITS; RECEPTORS, PURINERGIC;

EID: 84904251942     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12238     Document Type: Article

References (49)

1. Bliksøen M, etal. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Eur J Cardiothorac Surg 2008; 34: 344-349.
2. Crisostomo PR, etal. Preconditioning vs postoconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 2006; 202: 797-812.
3. Staat P, etal. Postconditioning the human heart. Circulation 2005; 112: 2143-2148.
4. Kin H, etal. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 2005; 67: 124-133.
5. McIntosh VJ, Lasley RD,. Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant? J Cardiovasc Pharmacol Ther 2012; 17: 21-33.
6. 2B-adenosine receptor agonist in human 293 cells and rabbit hearts. Basic Res Cardiol 2010; 105: 129-137.
7. 2B adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am J Physiol Heart Circ Physiol 2010; 299: H1262-H1264.
8. 2B receptor cascade. Cardiovasc Res 2006; 70: 308-314.
9. 3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium tolerance to ischemia. Am J Physiol Heart Circ Physiol 2001; 281: H1751-H1758.
10. 1 receptors and K(ATP) channels in both normal and hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2007; 49: 287-292.
11. 3 adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells. J Mol Cell Cardiol 2010; 49: 280-286.
12. 3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart. Cardiovasc Res 2002; 53: 147-155.
13. 2A receptor and Erk1/2. Cardiovasc Drugs Ther 2003; 17: 415-425.
14. 2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol 2007; 293: H2523-H2529.
15. 2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. Am J Physiol Heart Circ Physiol 2008; 295: H1825-H1833.
16. 2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 1998; 286: 611-618.
17. 1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc Res 1994; 28: 270-279.
18. Tsovolas K, etal. Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits. Pharmacol Res 2008; 57: 283-289.
19. 2B ligands. J Med Chem 2002; 45: 3271-3279.
20. Klotz KN, etal. Comparative pharmacology of adenosine receptor subtypes- characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 1998; 357: 1-9.
21. Volpini R, etal. Adenosine receptor agonists: synthesis and binding affinity of 2- (aryl)alkylthioadenosine derivatives. ARKIVOC 2004; 5: 301-311.
22. 3 receptor. J Med Chem 2009; 52: 7897-7900.
23. Fotopoulou T, etal. Design and synthesis of nitrate esters of aromatic heterocyclic compounds as pharmacological preconditioning agents. Bioorg Med Chem 2008; 16: 4523-4531.
24. Koufaki M, etal. Discovery of 6-(4-(6-nitroxyhexanoyl0piperazin-1-yl))- 9H-purine, as pharmacological postconditioning agent. Bioorg Med Chem 2012; 20: 5948-5956.
25. 1 agonist, attenuates myocardial reperfusion injury in rats. Eur J Pharmacol 1995; 279: 251-256.
26. 2 receptor agonists on myocardial reperfusion injury. Am Heart J 1992; 123: 332-338.
27. Xi L, etal. Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice. Circulation 2008; 118 (Suppl. 14): S32-S37.
28. Baxter GF, etal. Adenosine A1 agonist at reperfusion Trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study. Cardiovasc Drugs Ther 2000; 14: 607-614.
29. 1-receptor agonist, in myocardial ischaemia/reperfusion injury in the pig. J Cardiovasc Pharmacol 1999; 33: 285-291.
30. 1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659-665.
31. 2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol 2009; 47: 684-690.
32. 1 receptor-mediated cardioprotection. Am J Physiol Heart Circ Physiol 2011; 301: H1183-H1189.
33. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 1997; 280: 301-309.
34. Schlack W, etal. Adenosine A2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J Cardiovasc Pharmacol 1993; 22: 89-96.
35. Yang XM, etal. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 2004; 36: 411-421.
36. Zhao ZQ, etal. Adenosine inhibition of neutrophil damage during reperfusion does not involve KATP-channel activation. Am J Physiol 1997; 273 (4 Pt 2): H1677-H1687.
37. Auchampach JA, etal. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 2003; 285: H607-H613.
38. 3 receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am J Physiol Heart Circ Physiol 2002; 283: H1307-H1313.
39. Homeister JW, etal. Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation 1990; 82: 595-608.
40. Japertas P, etal. Fragmental methods in the design of new compounds. Applications of the advanced algorithm builder. Quant Struct Act Relat 2002; 21: 23-37.
41. Ballard-Croft C, etal. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments. Am J Physiol Heart Circ Physiol 2005; 288: H1359-H1366.
42. 3 receptors in newborn rat cardiomyocytes. J Mol Cell Cardiol 2004; 37: 989-999.
43. Germack R, Dickenson JM,. Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes. J Mol Cell Cardiol 2005; 39: 429-442.
44. Reid EA, etal. In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling. Am J Physiol Heart Circ Physiol 2005; 288: H2253-H2259.
45. Kuno A, etal. Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am J Physiol Heart Circ Physiol 2008; 295: H1288-H1295.
46. Dimmeler S, etal. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.
47. Li J, etal. Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo. PLoS ONE 2013; 8: e70331.
48. Kupai K, etal. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 2009; 297: H1729-H1735s.
49. Heusch G, etal. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 2011; 109: 1302-1308.